Xlife Sciences AG (SWX:XLS)
19.50
-3.00 (-13.33%)
At close: May 2, 2025, 5:20 PM CET
Xlife Sciences AG Cash Flow Statement
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Net Income | 34.28 | 14.88 | 14.31 | 53.42 | 21.46 | Upgrade
|
Depreciation & Amortization | 16.06 | 16.03 | 16.02 | 0.07 | 0.06 | Upgrade
|
Loss (Gain) From Sale of Assets | 1.42 | -18.43 | - | - | - | Upgrade
|
Asset Writedown & Restructuring Costs | -0 | 0 | 0 | - | - | Upgrade
|
Loss (Gain) From Sale of Investments | -56.54 | -15.88 | -34.76 | -59.92 | -24.31 | Upgrade
|
Loss (Gain) on Equity Investments | 13.23 | 7.8 | - | - | - | Upgrade
|
Other Operating Activities | -6.05 | 0.39 | 0.94 | 3.01 | 2.81 | Upgrade
|
Change in Accounts Receivable | -0 | -8.58 | -0.26 | -0.06 | 2.22 | Upgrade
|
Change in Accounts Payable | 0.05 | 0.34 | 0.25 | 0.04 | 0.06 | Upgrade
|
Change in Unearned Revenue | -3.05 | 2.88 | -1 | - | -2.66 | Upgrade
|
Change in Other Net Operating Assets | 0.18 | 0.74 | -0.1 | -0.88 | -0.04 | Upgrade
|
Operating Cash Flow | -0.42 | 0.17 | -4.61 | -4.32 | -0.4 | Upgrade
|
Capital Expenditures | -0.01 | -0.01 | -0.02 | -0.16 | -0.03 | Upgrade
|
Cash Acquisitions | -2.41 | -0.67 | -0.11 | -1.78 | -0.07 | Upgrade
|
Sale (Purchase) of Intangibles | - | -0.03 | -0.06 | -1.06 | -0.19 | Upgrade
|
Investment in Securities | - | - | - | -1.84 | -2.78 | Upgrade
|
Other Investing Activities | -1.58 | -0.3 | -1.49 | -2.2 | -0.79 | Upgrade
|
Investing Cash Flow | -4 | -1.01 | -1.68 | -7.03 | -3.86 | Upgrade
|
Short-Term Debt Issued | 4.41 | 0.84 | - | - | - | Upgrade
|
Total Debt Issued | 4.41 | 0.84 | - | - | - | Upgrade
|
Long-Term Debt Repaid | -0.11 | -0.11 | -0.11 | -0.03 | -0.05 | Upgrade
|
Net Debt Issued (Repaid) | 4.3 | 0.73 | -0.11 | -0.03 | -0.05 | Upgrade
|
Issuance of Common Stock | - | 0.11 | 5.01 | 9.36 | 7.06 | Upgrade
|
Other Financing Activities | - | -0.01 | -0.35 | -0.73 | -0.57 | Upgrade
|
Financing Cash Flow | 4.3 | 0.83 | 4.56 | 8.6 | 6.43 | Upgrade
|
Foreign Exchange Rate Adjustments | 0 | 0.01 | 0 | 0.02 | -0 | Upgrade
|
Miscellaneous Cash Flow Adjustments | 0 | -0 | -0 | 0 | - | Upgrade
|
Net Cash Flow | -0.12 | -0 | -1.74 | -2.75 | 2.16 | Upgrade
|
Free Cash Flow | -0.43 | 0.16 | -4.62 | -4.48 | -0.43 | Upgrade
|
Free Cash Flow Margin | -51.94% | 15.97% | -449.70% | -555.75% | -108.75% | Upgrade
|
Free Cash Flow Per Share | -0.06 | 0.02 | -0.64 | -0.72 | -0.07 | Upgrade
|
Cash Interest Paid | 0.18 | 0.08 | 0.26 | 0.22 | 0.17 | Upgrade
|
Cash Income Tax Paid | 0.11 | 0.05 | 0.08 | 0.02 | 0.04 | Upgrade
|
Levered Free Cash Flow | 6.47 | -10.47 | 1.52 | -4.97 | 3.01 | Upgrade
|
Unlevered Free Cash Flow | 6.77 | -10.23 | 1.95 | -4.66 | 3.13 | Upgrade
|
Change in Net Working Capital | -2.81 | 13.82 | 1.02 | 1 | -4.8 | Upgrade
|
Updated Sep 18, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.